People feel fuller when theyre on these medications. This delayed gastric emptying is one reason many patients experience reduced appetite and, in some cases, side effects
The FDA prescribing information for semaglutide and tirzepatide lists fatigue as an adverse reaction occurring in clinical studies, with incidence rates typically ranging from 5-11% depending on the specific product and dosage
Not everyone is a candidate for GLP-1 receptor agonists
Foundayo (Orforglipron): A newer oral option, Foundayo offers the convenience of anytime intake without the need for refrigeration, providing flexibility in your weight loss journey
Mistake #2: Expecting fast weight loss during the starting dose What goes wrong: The early phase is designed for tolerability , not maximal loss
Check your blood pressure at the same time each day, ideally in the morning before eating